JESSICA TEMPLETON: Open Payments
NPI 1164132031 · YORK, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$497 in 25 payments from 11 companies in 2025. Trend: 2023 $992 · 2024 $373 · 2025 $497
Food & beverage: $497
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $131 |
| PFIZER INC. | 5 | $87 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| Janssen Pharmaceuticals, Inc | 1 | $44 |
| Lilly USA, LLC | 2 | $40 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| EMD Serono, Inc. | 1 | $27 |
| Astellas Pharma US Inc | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: VRAYLAR, PREVNAR 20, AIRSUPRA, SPRAVATO, JARDIANCE, Kerendia, Veozah, UBRELVY.
Industry payments across PA — which companies pay providers there.
